Epstein-Barr virus EBNA1 protein regulates viral latency through effects on let-7 microRNA and Dicer

Journal of Virology

Volumn 88, Issue 19, 2014, Pages 11166-11177

  Mansouri, Sheila ^a   Pan, Qun ^b   Blencowe, Benjamin J ^a,b   Claycomb, Julie M ^a   Frappier, Lori ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DICER; EPSTEIN BARR VIRUS ANTIGEN 1; MICRORNA; MICRORNA LET 7A; UNCLASSIFIED DRUG; DEAD BOX PROTEIN; DICER1 PROTEIN, HUMAN; EBV ENCODED NUCLEAR ANTIGEN 1; EBV-ENCODED NUCLEAR ANTIGEN 1; EPSTEIN BARR VIRUS ANTIGEN; LUCIFERASE; MIRNLET7 MICRORNA, HUMAN; RIBONUCLEASE III; SMALL INTERFERING RNA;

3' UNTRANSLATED REGION; ARTICLE; BINDING SITE; CONTROLLED STUDY; DOWN REGULATION; EPSTEIN BARR VIRUS; GENE MAPPING; GENETIC TRANSCRIPTION; HIGH THROUGHPUT SEQUENCING; HISTONE ACETYLATION; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOREACTIVITY; LATENT PERIOD; MOLECULAR CLONING; NONHUMAN; PROTEIN AGGREGATION; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION; VIRUS REACTIVATION; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; HOST PATHOGEN INTERACTION; HUMAN; METABOLISM; REPORTER GENE; SIGNAL TRANSDUCTION; TUMOR CELL LINE; VIRUS LATENCY;

CELL LINE, TUMOR; DEAD-BOX RNA HELICASES; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENE EXPRESSION REGULATION; GENE SILENCING; GENES, REPORTER; HERPESVIRUS 4, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; LUCIFERASES; MICRORNAS; RIBONUCLEASE III; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; VIRUS LATENCY;

EID: 84906978953     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01785-14     Document Type: Article

References (85)

1. Fukayama M. 2010. Epstein-Barr virus and gastric carcinoma. Pathol. Int. 60:337-350. http://dx.doi.org/10.1111/j.1440-1827.2010.02533.x.
2. Raab-Traub N. 2002. Epstein-Barr virus in the pathogenesis of NPC. Semin. Cancer Biol. 12:431-441. http://dx.doi.org/10.1016/S1044579X0200086X.
3. Kenney SC, Mertz JE. 2014. Regulation of the latent-lytic switch in Epstein-Barr virus. Semin. Cancer Biol. 26:60-68. http://dx.doi.org/10.1016/j.semcancer.2014.01.002.
4. Cochet C, Martel-Renoir D, Grunewald V, Bosq J, Cochet G, Schwaab G, Bernaudin JF, Joab I. 1993. Expression of the Epstein-Barr virus immediate early gene, BZLF1, in nasopharyngeal carcinoma tumor cells. Virology 197:358-365. http://dx.doi.org/10.1006/viro.1993.1597.
5. Hong GK, Kumar P, Wang L, Damania B, Gulley ML, Delecluse HJ, Polverini PJ, Kenney SC. 2005. Epstein-Barr virus lytic infection is required for efficient production of the angiogenesis factor vascular endothelial growth factor in lymphoblastoid cell lines. J. Virol. 79:13984- 13992. http://dx.doi.org/10.1128/JVI.79.22.13984-13992.2005.
6. Klein G. 1989. Viral latency and transformation: the strategy of Epstein-Barr virus. Cell 58:5-8. http://dx.doi.org/10.1016/0092-8674(89)90394-2.
7. Yates JL, Warren N, Sugden B. 1985. Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells. Nature 313: 812-815. http://dx.doi.org/10.1038/313812a0.
8. Frappier L. 2012. EBNA1 and host factors in Epstein-Barr virus latent DNA replication. Curr. Opin. Virol. 2:733-739. http://dx.doi.org/10.1016/j.coviro.2012.09.005.
9. Reisman D, Sugden B. 1986. trans Activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1. Mol. Cell. Biol. 6:3838-3846.
10. Gahn T, Sugden B. 1995. An EBNA1 dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene. J. Virol. 69:2633-2636.
11. Wu H, Kapoor P, Frappier L. 2002. Separation of the DNA replication, segregation, and transcriptional activation functions of Epstein-Barr nuclear antigen 1. J. Virol. 76:2480-2490. http://dx.doi.org/10.1128/jvi.76.5.2480-2490.2002.
12. Ceccarelli DFJ, Frappier L. 2000. Functional analyses of the EBNA1 originDNAbinding protein of Epstein-Barr virus. J. Virol. 74:4939-4948. http://dx.doi.org/10.1128/JVI.74.11.4939-4948.2000.
13. Kennedy G, Sugden B. 2003. EBNA-1, a bifunctional transcriptional activator. Mol. Cell. Biol. 23:6901-6908. http://dx.doi.org/10.1128/MCB.23.19.6901-6908.2003.
14. Lin A, Wang S, Nguyen T, Shire K, Frappier L. 2008. The EBNA1 protein of Epstein-Barr virus functionally interacts with Brd4. J. Virol. 82:12009-12019. http://dx.doi.org/10.1128/JVI.01680-08.
15. Malik-Soni N, Frappier L. 2014. Nucleophosmin contributes to the transcriptional activation function of the Epstein-Barr virus EBNA1 protein. J. Virol. 88:2323-2326. http://dx.doi.org/10.1128/JVI.02521-13.
16. Wang S, Frappier L. 2009. Nucleosome assembly proteins bind to Epstein-Barr virus nuclear antigen 1 and affect its functions in DNA replication and transcriptional activation. J. Virol. 83:11704-11714. http://dx.doi.org/10.1128/JVI.00931-09.
17. Holowaty MN, Zeghouf M, Wu H, Tellam J, Athanasopoulos V, Greenblatt J, Frappier L. 2003. Protein profiling with Epstein-Barr nuclear antigen-1 reveals an interaction with the herpesvirus-associated ubiquitin-specific protease HAUSP/USP7. J. Biol. Chem. 278:29987-29994. http://dx.doi.org/10.1074/jbc.M303977200.
18. Frappier L. 2012. Role of EBNA1 in NPC tumourigenesis. Semin. Cancer Biol. 22:154-161. http://dx.doi.org/10.1016/j.semcancer.2011.12.002.
19. Frappier L. 2012. Contributions of Epstein-Barr nuclear antigen 1 (EBNA1) to cell immortalization and survival. Viruses 4:1537-1547. http://dx.doi.org/10.3390/v4091537.
20. Saridakis V, Sheng Y, Sarkari F, Holowaty MN, Shire K, Nguyen T, Zhang RG, Liao J, Lee W, Edwards AM, Arrowsmith CH, Frappier L. 2005. Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1: implications for EBV-mediated immortalization. Mol. Cell 18:25-36. http://dx.doi.org/10.1016/j.molcel.2005.02.029.
21. Sivachandran N, Sarkari F, Frappier L. 2008. Epstein-Barr nuclear antigen 1 contributes to nasopharyngeal carcinoma through disruption of PML nuclear bodies. PLoS Pathog. 4:e1000170. http://dx.doi.org/10.1371/journal.ppat.1000170.
22. Wood VH, O'Neil JD, Wei W, Stewart SE, Dawson CW, Young LS. 2007. Epstein-Barr virus-encoded EBNA1 regulates cellular gene transcription and modulates the STAT1 and TGFbeta signaling pathways. Oncogene 26:4135-4147. http://dx.doi.org/10.1038/sj.onc.1210496.
23. Valentine R, Dawson CW, Hu C, Shah KM, Owen TJ, Date KL, Maia SP, Shao J, Arrand JR, Young LS, O'Neil JD. 2010. Epstein-Barr virusencoded EBNA1 inhibits the canonical NF-kappaB pathway in carcinoma cells by inhibiting IKK phosphorylation. Mol. Cancer 9:1. http://dx.doi.org/10.1186/1476-4598-9-1.
24. Gruhne B, Sompallae R, Marescotti D, Kamranvar SA, Gastaldello S, Masucci MG. 2009. The Epstein-Barr virus nuclear antigen-1 promotes genomic instability via induction of reactive oxygen species. Proc. Natl. Acad. Sci. U. S. A. 106:2313-2318. http://dx.doi.org/10.1073/pnas.0810619106.
25. Cao JY, Mansouri S, Frappier L. 2012. Changes in the nasopharyngeal carcinoma nuclear proteome induced by the EBNA1 protein of Epstein-Barr virus reveal potential roles for EBNA1 in metastasis and oxidative stress responses. J. Virol. 86:382-394. http://dx.doi.org/10.1128/JVI.05648-11.
26. Canaan A, Haviv I, Urban AE, Schulz VP, Hartman S, Zhang Z, Palejev D, Deisseroth AB, Lacy J, Snyder M, Gerstein M, Weissman SM. 2009. EBNA1 regulates cellular gene expression by binding cellular promoters. Proc. Natl. Acad. Sci. U. S. A. 106:22421-22426. http://dx.doi.org/10.1073/pnas.0911676106.
27. Lu J, Murakami M, Verma SC, Cai Q, Haldar S, Kaul R, Wasik MA, Middeldorp J, Robertson ES. 2011. Epstein-Barr virus nuclear antigen 1 (EBNA1) confers resistance to apoptosis in EBV-positive B-lymphoma cells through up-regulation of survivin. Virology 410:64-75. http://dx.doi.org/10.1016/j.virol.2010.10.029.
28. Skalsky RL, Corcoran DL, Gottwein E, Frank CL, Kang D, Hafner M, Nusbaum JD, Feederle R, Delecluse HJ, Luftig MA, Tuschl T, Ohler U, Cullen BR. 2012. The viral and cellular microRNA targetome in lymphoblastoid cell lines. PLoS Pathog. 8:e1002484. http://dx.doi.org/10.1371/journal.ppat.1002484.
29. Barth S, Meister G, Grasser FA. 2011. EBV-encoded miRNAs. Biochim. Biophys. Acta 1809:631-640. http://dx.doi.org/10.1016/j.bbagrm.2011.05.010.
30. Cullen BR. 2004. Transcription and processing of human microRNA precursors. Mol. Cell 16:861-865. http://dx.doi.org/10.1016/j.molcel.2004.12.002.
31. Wilson RC, Doudna JA. 2013. Molecular mechanisms of RNA interference. Annu. Rev. Biophys. 42:217-239. http://dx.doi.org/10.1146/annurev-biophys-083012-130404.
32. Yates LA, Norbury CJ, Gilbert RJ. 2013. The long and short of microRNA. Cell 153:516-519. http://dx.doi.org/10.1016/j.cell.2013.04.003.
33. Stahlhut C, Slack FJ. 2013. MicroRNAs and the cancer phenotype: profiling, signatures and clinical implications. Genome Med. 5:111. http://dx.doi.org/10.1186/gm516.
34. Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S, Miyazono K. 2009. Modulation of microRNA processing by p53. Nature 460:529-533. http://dx.doi.org/10.1038/nature08199.
35. Wang G, Cao X, Lai S, Luo X, Feng Y, Wu J, Ning Q, Xia X, Wang J, Gong J, Hu J. 17 March 2014. Altered p53 regulation of miR-148b and p55PIK contributes to tumor progression in colorectal cancer. Oncogene http://dx.doi.org/10.1038/onc.2014.30.
36. Zhang X, Wan G, Berger FG, He X, Lu X. 2011. The ATM kinase induces microRNA biogenesis in the DNA damage response. Mol. Cell 41:371- 383. http://dx.doi.org/10.1016/j.molcel.2011.01.020.
37. Cameron JE, Yin Q, Fewell C, Lacey M, McBride J, Wang X, Lin Z, Schaefer BC, Flemington EK. 2008. Epstein-Barr virus latent membrane protein 1 induces cellular microRNA miR-146a, a modulator of lymphocyte signaling pathways. J. Virol. 82:1946-1958. http://dx.doi.org/10.1128/JVI.02136-07.
38. Rosato P, Anastasiadou E, Garg N, Lenze D, Boccellato F, Vincenti S, Severa M, Coccia EM, Bigi R, Cirone M, Ferretti E, Campese AF, Hummel M, Frati L, Presutti C, Faggioni A, Trivedi P. 2012. Differential regulation of miR-21 and miR-146a by Epstein-Barr virusencoded EBNA2. Leukemia 26:2343-2352. http://dx.doi.org/10.1038/leu.2012.108.
39. Ellis-Connell AL, Iempridee T, Xu I, Mertz JE. 2010. Cellular microRNAs 200b and 429 regulate the Epstein-Barr virus switch between latency and lytic replication. J. Virol. 84:10329-10343. http://dx.doi.org/10.1128/JVI.00923-10.
40. Klinke O, Feederle R, Delecluse HJ. 2014. Genetics of Epstein-Barr virus microRNAs. Semin. Cancer Biol. 26:52-59. http://dx.doi.org/10.1016/j.semcancer.2014.02.002.
41. Cheung ST, Huang DP, Hui AB, Lo KW, Ko CW, Tsang YS, Wong N, Whitney BM, Lee JC. 1999. Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus. Int. J. Cancer 83:121-126. http://dx.doi.org/10.1002/(SICI)1097-0215(19990924)83:<121::AID-IJC21>3.0.CO;2-F.
42. Borza CM, Hutt-Fletcher LM. 2002. Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nat. Med. 8:594- 599. http://dx.doi.org/10.1038/nm0602-594.
43. Lo AK, Lo KW, Tsao SW, Wong HL, Hui JW, To KF, Hayward DS, Chui YL, Lau YL, Takada K, Huang DP. 2006. Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells. Neoplasia 8:173-180. http://dx.doi.org/10.1593/neo.05625.
44. Maruo S, Yang L, Takada K. 2001. Roles of Epstein-Barr virus glycoproteins gp350 and gp25 in the infection of human epithelial cells. J. Gen. Virol. 82:2373-2383.
45. Sun Y, Hegamyer G, Cheng YJ, Hildesheim A, Chen JY, Chen IH, Cao Y, Yao KT, Colburn NH. 1992. An infrequent point mutation of the p53 gene in human nasopharyngeal carcinoma. Proc. Natl. Acad. Sci. U. S. A. 89:6516-6520. http://dx.doi.org/10.1073/pnas.89.14.6516.
46. 2-terminal kinase without causing apoptosis. Int. J. Biochem. Cell Biol. 40:2452-2461. http://dx.doi.org/10.1016/j.biocel.2008.04.021.
47. Gu W, Claycomb JM, Batista PJ, Mello CC, Conte D. 2011. Cloning Argonaute-associated small RNAs from Caenorhabditis elegans. Methods Mol. Biol. 725:251-280. http://dx.doi.org/10.1007/978-1-61779-046-1_17.
48. Griffiths-Jones S. 2004. The microRNA registry. Nucleic Acids Res. 32: D109-D111. http://dx.doi.org/10.1093/nar/gkh023.
49. Kent WJ. 2002. BLAT-the BLAST-like alignment tool. Genome Res. 12:656-664. http://dx.doi.org/10.1101/gr.229202.
50. Malik-Soni N, Frappier L. 2012. Proteomic profiling of EBNA1-host protein interactions in latent and lytic Epstein-Barr virus infections. J. Virol. 86:6999-7002. http://dx.doi.org/10.1128/JVI.00194-12.
51. Chen M-R, Middeldorp JM, Hayward SD. 1993. Separation of the complex DNA binding domain of EBNA-1 into DNA recognition and dimerization subdomains of novel structure. J. Virol. 67:4875-4885.
52. Tokumaru S, Suzuki M, Yamada H, Nagino M, Takahashi T. 2008. let-7 regulates Dicer expression and constitutes a negative feedback loop. Carcinogenesis 29:2073-2077. http://dx.doi.org/10.1093/carcin/bgn187.
53. Kumar MS, Erkeland SJ, Pester RE, Chen CY, Ebert MS, Sharp PA, Jacks T. 2008. Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc. Natl. Acad. Sci. U. S. A. 105:3903-3908. http://dx.doi.org/10.1073/pnas.0712321105.
54. Olive V, Bennett MJ, Walker JC, Ma C, Jiang I, Cordon-Cardo C, Li QJ, Lowe SW, Hannon GJ, He L. 2009. miR-19 is a key oncogenic component of mir-17-92. Genes Dev. 23:2839-2849. http://dx.doi.org/10.1101/gad.1861409.
55. Forman JJ, Legesse-Miller A, Coller HA. 2008. A search for conserved sequences in coding regions reveals that the let-7 microRNA targets Dicer within its coding sequence. Proc. Natl. Acad. Sci. U. S. A. 105:14879- 14884. http://dx.doi.org/10.1073/pnas.0803230105.
56. Jakymiw A, Patel RS, Deming N, Bhattacharyya I, Shah P, Lamont RJ, Stewart CM, Cohen DM, Chan EK. 2010. Overexpression of Dicer as a result of reduced let-7 microRNA levels contributes to increased cell proliferation of oral cancer cells. Genes Chromosomes Cancer 49:549-559. http://dx.doi.org/10.1002/gcc.20765.
57. Iizasa H, Wulff BE, Alla NR, Maragkakis M, Megraw M, Hatzigeorgiou A, Iwakiri D, Takada K, Wiedmer A, Showe L, Lieberman P, Nishikura K. 2010. Editing of Epstein-Barr virus-encoded BART6 microRNAs controls their Dicer targeting and consequently affects viral latency. J. Biol. Chem. 285:33358-33370. http://dx.doi.org/10.1074/jbc.M110.138362.
58. Sivachandran N, Wang X, Frappier L. 2012. Functions of the Epstein-Barr virus EBNA1 protein in viral reactivation and lytic infection. J. Virol. 86:6146-6158. http://dx.doi.org/10.1128/JVI.00013-12.
59. Sivachandran N, Cao JY, Frappier L. 2010. Epstein-Barr virus nuclear antigen 1 hijacks the host kinase CK2 to disrupt PML nuclear bodies. J. Virol. 84:11113-11123. http://dx.doi.org/10.1128/JVI.01183-10.
60. Norseen J, Johnson FB, Lieberman PM. 2009. Role for G-quadruplex RNA binding by Epstein-Barr virus nuclear antigen 1 in DNA replication and metaphase chromosome attachment. J. Virol. 83:10336-10346. http://dx.doi.org/10.1128/JVI.00747-09.
61. Snudden DK, Hearing J, Smith PR, Grasser FA, Griffin BE. 1994. EBNA-1, the major nuclear antigen of Epstein-Barr virus, resembles 'RGG' RNA binding proteins. EMBO J. 13:4840-4847.
62. Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE, Horvitz HR, Ruvkun G. 2000. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 403:901-906. http://dx.doi.org/10.1038/35002607.
63. Pasquinelli AE, Reinhart BJ, Slack F, Martindale MQ, Kuroda MI, Maller B, Hayward DC, Ball EE, Degnan B, Muller P, Spring J, Srinivasan A, Fishman M, Finnerty J, Corbo J, Levine M, Leahy P, Davidson E, Ruvkun G. 2000. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature 408:86-89. http://dx.doi.org/10.1038/35040556.
64. Roush S, Slack FJ. 2008. The let-7 family of microRNAs. Trends Cell Biol. 18:505-516. http://dx.doi.org/10.1016/j.tcb.2008.07.007.
65. Boyerinas B, Park SM, Hau A, Murmann AE, Peter ME. 2010. The role of let-7 in cell differentiation and cancer. Endocr. Relat. Cancer 17:F19- F36. http://dx.doi.org/10.1677/ERC-09-0184.
66. Wang X, Cao L, Wang Y, Liu N, You Y. 2012. Regulation of let-7 and its target oncogenes (review). Oncol. Lett. 3:955-960. http://dx.doi.org/10.3892/ol.2012.609.
67. Dahiya N, Sherman-Baust CA, Wang TL, Davidson B, Shih I-M, Zhang Y, Wood W, III, Becker KG, Morin PJ. 2008. MicroRNA expression and identification of putative miRNA targets in ovarian cancer. PLoS One 3:e2436. http://dx.doi.org/10.1371/journal.pone.0002436.
68. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y, Mitsudomi T, Takahashi T. 2004. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res. 64: 3753-3756. http://dx.doi.org/10.1158/0008-5472.CAN-04-0637.
69. O'Hara AJ, Wang L, Dezube BJ, Harrington WJ, Jr., Damania B, Dittmer DP. 2009. Tumor suppressor microRNAs are underrepresented in primary effusion lymphoma and Kaposi sarcoma. Blood 113:5938- 5941. http://dx.doi.org/10.1182/blood-2008-09-179168.
70. Brueckner B, Stresemann C, Kuner R, Mund C, Musch T, Meister M, Sultmann H, Lyko F. 2007. The human let-7a-3 locus contains an epigenetically regulated microRNA gene with oncogenic function. Cancer Res. 67:1419-1423. http://dx.doi.org/10.1158/0008-5472.CAN-06-4074.
71. Lenarduzzi M, Hui AB, Alajez NM, Shi W, Williams J, Yue S, O'Sullivan B, Liu FF. 2013. MicroRNA-193b enhances tumor progression via down regulation of neurofibromin 1. PLoS One 8:e53765. http://dx.doi.org/10.1371/journal.pone.0053765.
72. Gao XN, Lin J, Gao L, Li YH, Wang LL, Yu L. 2011. MicroRNA-193b regulates c-Kit proto-oncogene and represses cell proliferation in acute myeloid leukemia. Leuk. Res. 35:1226-1232. http://dx.doi.org/10.1016/j.leukres.2011.06.010.
73. Li XF, Yan PJ, Shao ZM. 2009. Downregulation of miR-193b contributes to enhance urokinase-type plasminogen activator (uPA) expression and tumor progression and invasion in human breast cancer. Oncogene 28: 3937-3948. http://dx.doi.org/10.1038/onc.2009.245.
74. Tagawa H, Seto M. 2005. A microRNA cluster as a target of genomic amplification in malignant lymphoma. Leukemia 19:2013-2016. http://dx.doi.org/10.1038/sj.leu.2403942.
75. Hayashita Y, Osada H, Tatematsu Y, Yamada H, Yanagisawa K, Tomida S, Yatabe Y, Kawahara K, Sekido Y, Takahashi T. 2005. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res. 65:9628-9632. http://dx.doi.org/10.1158/0008-5472.CAN-05-2352.
76. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S, Powers S, Cordon-Cardo C, Lowe SW, Hannon GJ, Hammond SM. 2005. A microRNA polycistron as a potential human oncogene. Nature 435:828-833. http://dx.doi.org/10.1038/nature03552.
77. Li Y, Vecchiarelli-Federico LM, Li YJ, Egan SE, Spaner D, Hough MR, Ben-David Y. 2012. The miR-17-92 cluster expands multipotent hematopoietic progenitors whereas imbalanced expression of its individual oncogenic miRNAs promotes leukemia in mice. Blood 119:4486-4498. http://dx.doi.org/10.1182/blood-2011-09-378687.
78. Wang Z, Lin S, Li JJ, Xu Z, Yao H, Zhu X, Xie D, Shen Z, Sze J, Li K, Lu G, Chan DT, Poon WS, Kung HF, Lin MC. 2011. MYC protein inhibits transcription of the microRNA cluster MC-let-7a-1∼let-7d via noncanonical E-box. J. Biol. Chem. 286:39703-39714. http://dx.doi.org/10.1074/jbc.M111.293126.
79. Sun D, Layer R, Mueller AC, Cichewicz MA, Negishi M, Paschal BM, Dutta A. 2014. Regulation of several androgen-induced genes through the repression of the miR-99a/let-7c/miR-125b-2 miRNA cluster in prostate cancer cells. Oncogene 33:1448-1457. http://dx.doi.org/10.1038/onc.2013.77.
80. Johnson CD, Esquela-Kerscher A, Stefani G, Byrom M, Kelnar K, Ovcharenko D, Wilson M, Wang X, Shelton J, Shingara J, Chin L, Brown D, Slack FJ. 2007. The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res. 67:7713-7722. http://dx.doi.org/10.1158/0008-5472.CAN-07-1083.
81. Martello G, Rosato A, Ferrari F, Manfrin A, Cordenonsi M, Dupont S, Enzo E, Guzzardo V, Rondina M, Spruce T, Parenti AR, Daidone MG, Bicciato S, Piccolo S. 2010. A microRNA targeting Dicer for metastasis control. Cell 141:1195-1207. http://dx.doi.org/10.1016/j.cell.2010.05.017.
82. Ellis AL, Wang Z, Yu X, Mertz JE. 2010. Either ZEB1 or ZEB2/SIP1 can play a central role in regulating the Epstein-Barr virus latent-lytic switch in a cell-type-specific manner. J. Virol. 84:6139-6152. http://dx.doi.org/10.1128/JVI.02706-09.
83. Marquitz AR, Mathur A, Chugh PE, Dittmer DP, Raab-Traub N. 2014. Expression profile of microRNAs in Epstein-Barr virus-infected AGS gastric carcinoma cells. J. Virol. 88:1389-1393. http://dx.doi.org/10.1128/JVI.02662-13.
84. Zhao H, Jin X, Su H, Deng X, Fang Y, Shen L, Xie C. 2014. Downregulation of Dicer expression in cervical cancer tissues. Med. Oncol. 31: 937. http://dx.doi.org/10.1007/s12032-014-0937-0.
85. Wang L, Tian WD, Xu X, Nie B, Lu J, Liu X, Zhang B, Dong Q, Sunwoo JB, Li G, Li XP. 2014. Epstein-Barr virus nuclear antigen 1 (EBNA1) protein induction of epithelial-mesenchymal transition in nasopharyngeal carcinoma cells. Cancer 120:363-372. http://dx.doi.org/10.1002/cncr.28418.